LEADER 01097nam--2200385---450- 001 990002844520203316 005 20061211163756.0 010 $a0-07-138224-0 035 $a000284452 035 $aUSA01000284452 035 $a(ALEPH)000284452USA01 035 $a000284452 100 $a20061211d2002----km-y0itay50------ba 101 $aeng 102 $aUS 105 $aa---||||001yy 200 1 $a<> Invisible future$ethe seamless integration of technology into everyday life$fPeter J. Denning, editor 210 $aNew York [etc.]$cMcGraw-Hill$dc2002 215 $aXIII, 348 p.$cill.$d24 cm. 410 0$12001 454 1$12001 461 1$1001-------$12001 606 0 $aInnovazioni tecnologiche 606 0 $aTecnologia dell'informazione 676 $a600 702 1$aDENNING,$bPeter J. 801 0$aIT$bsalbc$gISBD 912 $a990002844520203316 951 $aEG/94$b2029$cEG 959 $aBK 969 $aDIMEC 979 $aDIMEC$b90$c20061211$lUSA01$h1637 979 $aDIMEC$b90$c20061211$lUSA01$h1637 996 $aInvisible future$9993231 997 $aUNISA LEADER 09325nam 2200697 a 450 001 9910970047603321 005 20251017110129.0 010 $a9786610196333 010 $a9781280196331 010 $a1280196335 010 $a9780309584630 010 $a0309584639 010 $a9780585020150 010 $a0585020159 035 $a(CKB)110986584751198 035 $a(OCoLC)42328757 035 $a(CaPaEBR)ebrary10055262 035 $a(SSID)ssj0000145894 035 $a(PQKBManifestationID)11158198 035 $a(PQKBTitleCode)TC0000145894 035 $a(PQKBWorkID)10182167 035 $a(PQKB)11595024 035 $a(Au-PeEL)EBL3376238 035 $a(CaPaEBR)ebr10055262 035 $a(OCoLC)923262253 035 $a(MiAaPQ)EBC3376238 035 $a(Perlego)4737601 035 $a(DNLM)739418 035 $a(BIP)484972 035 $a(EXLCZ)99110986584751198 100 $a19920715d1992 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEmerging infections $emicrobial threats to health in the United States /$fJoshua Lederberg, Robert E. Shope, and Stanley C. Oaks, Jr., editors 205 $a1st ed. 210 $aWashington, D.C. $cNational Academy Press$d1992 215 $a1 online resource (308 p.) 300 $a"Committee on Emerging Microbial Threats to Health, Division of Health Sciences Policy, Division of International Health, Institute of Medicine." 311 08$a9780309047418 311 08$a0309047412 320 $aIncludes bibliographical references (p. 170-191) and index. 327 $aEMERGING INFECTIONS -- Copyright -- Preface -- Acknowledgments -- Contents -- Executive Summary -- RECOGNITION -- INTERVENTION -- The U.S. Public Health System -- Research and Training -- Vaccine and Drug Development -- VACCINES -- ANTIMICROBIAL DRUGS -- Vector Control -- Public Education and Behavioral Change -- 1 Background -- PLAGUE -- INFLUENZA -- OPTIMISM AND INDIFFERENCE -- Sanitation and Hygiene -- Quarantine -- Smallpox -- Poliomyelitis -- TROUBLE AHEAD -- Lyme Disease -- Peptic Ulcer -- Malaria -- Dengue -- Tuberculosis -- NEXT STEPS -- 2 Factors in Emergence -- THE CONCEPT OF EMERGENCE -- HUMAN DEMOGRAPHICS AND BEHAVIOR -- Population Growth, Density, and Distribution -- DENGUE -- Immunosuppression -- Sexual Activity and Substance Abuse -- TECHNOLOGY AND INDUSTRY -- Modern Medicine -- HEALTH CARE DELIVERY -- PREVENTION OF NOSOCOMIAL INFECTIONS -- Food Processing and Handling -- AGRICULTURAL CONDITIONS AND PRACTICES -- FOOD PROCESSING AND PRESERVATION TECHNOLOGIES -- DEMOGRAPHICS -- CONSUMER ATTITUDES AND BEHAVIOR -- COMMERCE -- DIET AND FOOD PREPARATION -- Trichinosis -- Anisakiasis -- Water Treatment -- ECONOMIC DEVELOPMENT AND LAND USE -- Dam Building and Rift Valley Fever -- Reforestation and Lyme Disease -- Global Warming -- INTERNATIONAL TRAVEL AND COMMERCE -- Travel -- MALARIA -- Commerce -- HANTAAN AND RELATED HANTAVIRUSES -- THE FILOVIRUSES -- MICROBIAL ADAPTATION AND CHANGE -- Natural Variation/Mutation -- RNA VIRUSES -- Influenza A Virus -- Human Immunodeficiency Virus -- DNA VIRUSES -- Hepatitis B Virus -- BACTERIA -- Brazilian Purpuric Fever -- Selective Pressure and the Development of Resistance -- RESISTANCE TO ANTIBIOTICS -- Pneumococci -- Staphylococci and Enterococci -- Pseudomonas aeruginosa -- Mycobacterium tuberculosis -- RESISTANCE TO ANTIVIRALS -- Acyclovir and Herpes Simplex Virus. 327 $aZidovudine and Human Immunodeficiency Virus-1 -- RESISTANCE TO ANTIMALARIALS -- VECTOR RESISTANCE TO PESTICIDES -- New Understandings: Microbes as Cofactors in Chronic Disease -- HUMAN T-CELL LEUKEMIA VIRUS TYPES I AND II -- ATHEROSCLEROSIS -- HUMAN PAPILLOMAVIRUS -- BREAKDOWN OF PUBLIC HEALTH MEASURES -- Inadequate Sanitation: Cholera -- Complacency -- INADEQUATE LEVELS OF IMMUNIZATION: MEASLES -- War -- 3 Addressing the Threats -- RECOGNITION -- Surveillance in Action: The World Health Organization's Smallpox Eradication Program -- LESSONS FROM THE SMALLPOX EXPERIENCE -- Current U.S.-Supported Surveillance Efforts -- DOMESTIC EFFORTS -- Notifiable Diseases Surveillance -- Nosocomial Infections Surveillance -- Outbreak Surveillance -- Influenza Surveillance -- Access to Surveillance Information -- INTERNATIONAL EFFORTS -- Past Successes -- Loss of Capacity -- Current Efforts -- Multilateral International Surveillance Efforts -- WORLD HEALTH ORGANIZATION -- PAN AMERICAN HEALTH ORGANIZATION -- The Concept of Global Surveillance -- INTERVENTION -- The U.S. Public Health System -- Research and Training -- THE ROCKEFELLER FOUNDATION -- NATIONAL INSTITUTES OF HEALTH -- CENTERS FOR DISEASE CONTROL -- DEPARTMENT OF DEFENSE -- OTHER PROGRAMS -- Vaccine and Drug Development -- VACCINES -- ANTIMICROBIAL DRUGS -- Vector Control -- VECTOR-CONTROL RESOURCES -- PESTICIDES FOR VECTOR CONTROL -- Public Education and Behavioral Change -- References -- Appendixes -- A Task Forces -- TASK FORCE 1 -- Bacteria, Rickettsiae, and Chlamydiae -- TASK FORCE 2 -- Viruses -- TASK FORCE 3 -- Protozoans, Helminths, and Fungi -- TASK FORCE 4 -- Policy Options -- TASK FORCE 5 -- Recommendations -- B Catalog of Emerging Infectious Disease Agents -- EMERGENT BACTERIA, RICKETTSIAE, AND CHLAMYDIAE -- Aeromonas -- Borrelia burgdorferi -- Campylobacter jejuni. 327 $aChlamydia pneumoniae (TWAR Strain) -- Chlamydia trachomatis -- Clostridium difficile -- Ehrlichia chaffeensis -- Escherichia coli O157:H7 -- Haemophilus influenzae biogroup aegyptius -- Helicobacter pylori -- Legionella pneumophila -- Listeria monocytogenes -- Mycobacterium tuberculosis -- Staphylococcus aureus (and Toxic Shock Syndrome) -- Streptococcus pyogenes (Group A) -- Vibrio cholerae -- Vibrio vulnificus -- EMERGENT VIRUSES -- Bovine Spongiform Encephalopathy Agent -- California Serogroup Viruses (LaCrosse, Jamestown Canyon, California Encephalitis) -- Chikungunya Virus -- Crimean-Congo Hemorrhagic Fever Virus -- Dengue Virus -- Filoviruses (Marburg, Ebola) -- Hantaviruses (Hantaan, Puumala, and Seoul) -- Hepatitis B Virus -- Hepatitis C Virus -- Hepatitis E Agent -- Human Herpesvirus-6 -- Human Immunodeficiency Virus (HIV), Types 1 and 2 -- Human Papillomavirus (HPV) -- Human Parvovirus B19 -- Human T-Cell Leukemia Virus (HTLV), Types 1 and 2 -- Influenza A Virus -- Japanese Encephalitis Virus -- Lassa Virus -- Measles Virus -- Norwalk and Norwalk-like Agents -- Rabies Virus -- Rift Valley Fever Virus -- Ross River Virus -- Rotavirus -- Venezuelan Equine Encephalitis (VEE) Virus -- Yellow Fever Virus -- EMERGENT PROTOZOANS, HELMINTHS, AND FUNGI -- Anisakis -- Babesia -- Candida -- Crytococcus -- Cryptosporidium -- Giardia lamblia -- Microsporidia -- Plasmodium -- Pneumocystis carinii -- Strongyloides stercoralis -- Toxoplasma gondii -- C Global Resources for Infectious Disease Surveillance -- U.S. and U.S. Affiliated -- U.S. Department of Defense -- Public Health Service -- International -- World Health Organization, Geneva, Switzerland -- Pasteur Institutes -- D Committee and Staff Biographies -- COMMITTEE -- STAFF -- Glossary -- Acronyms and Abbreviations -- Index. 330 $aThe emergence of HIV disease and AIDS, the reemergence of tuberculosis, and the increased opportunity for disease spread through international travel demonstrate the critical importance of global vigilance for infectious diseases. This volume highlights risk factors for the emergence of microbial threats to health, warns against complacency in public health, and promotes early prevention as a cost-effective and crucial strategy for maintaining public health in the United States and worldwide. The volume identifies infectious disease threats posed by bacteria and viruses, as well as protozoans, helminths, and fungi. Rich in information, it includes a historical perspective on infectious disease, with focuses on Lyme disease, peptic ulcer, malaria, dengue, and recent increases in tuberculosis. The panel discusses how "new" diseases arise and how "old" ones resurge and considers the roles of human demographics and behavior, technology and industry, economic development and land use, international travel and commerce, microbial adaptation and change, and breakdown of public health measures in changing patterns of infectious disease. Also included are discussions and recommendations on disease surveillance; vaccine, drug, and pesticide development; vector control; public education and behavioral change; research and training; and strengthening of the U.S. public health system. This volume will be of immediate interest to scientists specializing in all areas of infectious dieseases and microbiology, healthy policy specialists, public health officials, physicians, and medical faculty and students, as well as anyone interested in how their health can be threatened by infectious diseases. 606 $aEmerging infectious diseases$zUnited States 615 0$aEmerging infectious diseases 676 $a614.4/273 701 $aLederberg$b Joshua$095738 701 $aShope$b Robert E$01808555 701 $aOaks$b S. C$01808556 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910970047603321 996 $aEmerging infections$94358865 997 $aUNINA